ArticleJournal of surgical case reports2025
Phototherapeutic keratectomy for calcific band keratopathy secondary to multiple myeloma.
Article in Journal of surgical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To report a case of calcific band keratopathy (CBK) secondary to multiple myeloma (MM) successfully treated with phototherapeutic keratectomy (PTK). An 80-year-old woman presented with progressive vision loss in her left eye with a best corrected visual acuity (BCVA) of 4/10 in the left eye (OS). Slit-lamp examination revealed a central band-like corneal opacification indicative of CBK. Anterior segment optical coherence tomography (AS-OCT) showed a subepithelial hyper reflective layer. Further evaluation confirmed an indolent IgAk MM, with no indication for systemic therapy. PTK was performed using the Technolas® TENEO™ 317 M2 excimer laser, resulting in corneal surface regularization and BCVA improvement. At 1-year follow-up, the patient was asymptomatic, had a clear cornea, normal topography, and a BCVA of 10/10. CBK can be associated with systemic conditions. PTK is an effective and safe procedure for managing CBK, and can provide complete visual rehabilitation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.